Deutsche Bank Ag\ Castle Biosciences Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Castle Biosciences Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 60,172 shares of CSTL stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,172

Previous 309,511 80.56%

Holding current value

$1.69 Million

Previous $6.74 Million 74.53%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$17.4 - $31.47 $4.34 Million - $7.85 Million	-249,339 Reduced 80.56%	60,172 $1.72 Million
Q2 2024 Aug 14, 2024	BUY	$18.84 - $24.94 $879,884 - $1.16 Million	46,703 Added 17.77%	309,511 $6.74 Million
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $1.93 Million - $2.71 Million	106,978 Added 68.65%	262,808 $5.82 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $1.73 Million - $3.18 Million	141,792 Added 1010.06%	155,830 $3.36 Million
Q3 2023 Nov 09, 2023	BUY	$13.28 - $20.3 $42,190 - $64,493	3,177 Added 29.25%	14,038 $237,000
Q2 2023 Aug 14, 2023	SELL	$11.66 - $26.0 $50,954 - $113,620	-4,370 Reduced 28.69%	10,861 $149,000
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $84,421 - $123,532	4,336 Added 39.8%	15,231 $346,000
Q4 2022 Feb 13, 2023	BUY	$18.08 - $30.0 $2,928 - $4,860	162 Added 1.51%	10,895 $256,000
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $11,480 - $17,503	-510 Reduced 4.54%	10,733 $280,000
Q2 2022 Aug 11, 2022	SELL	$16.0 - $45.99 $16,144 - $46,403	-1,009 Reduced 8.24%	11,243 $247,000
Q1 2022 May 13, 2022	SELL	$33.17 - $46.98 $51,678 - $73,194	-1,558 Reduced 11.28%	12,252 $549,000
Q4 2021 Feb 11, 2022	SELL	$39.06 - $67.58 $352,477 - $609,841	-9,024 Reduced 39.52%	13,810 $592,000
Q3 2021 Nov 04, 2021	BUY	$60.13 - $77.6 $448,690 - $579,051	7,462 Added 48.54%	22,834 $1.52 Million
Q2 2021 Aug 11, 2021	BUY	$50.07 - $76.78 $183,156 - $280,861	3,658 Added 31.23%	15,372 $1.13 Million
Q1 2021 May 13, 2021	BUY	$58.92 - $97.33 $81,486 - $134,607	1,383 Added 13.39%	11,714 $801,000
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $54,761 - $91,750	1,256 Added 13.84%	10,331 $693,000
Q3 2020 Nov 12, 2020	BUY	$38.47 - $52.03 $154,457 - $208,900	4,015 Added 79.35%	9,075 $467,000
Q2 2020 Aug 13, 2020	BUY	$27.28 - $43.01 $47,112 - $74,278	1,727 Added 51.82%	5,060 $191,000
Q1 2020 May 14, 2020	BUY	$23.08 - $35.53 $46,598 - $71,735	2,019 Added 153.65%	3,333 $99,000
Q4 2019 Feb 14, 2020	BUY	$15.74 - $35.04 $4,580 - $10,196	291 Added 28.45%	1,314 $44,000
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $18,506 - $28,562	1,023 New	1,023 $16,000

Others Institutions Holding CSTL

# of Institutions

202

Shares Held

26M

Call Options Held

303K

Put Options Held

30.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $739M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account